Consistent with GLP1 receptor agonists being developed initially to treat T2D, 23.1% of survey participants reported using GLP1 medication to improve blood sugar
For clinicians and researchers in India, especially in Mumbai, it offers a promising pathway toward metabolic health innovation
Diabetic Retinopathy and Diabetic Eye Disease Typically thought of as a retinal microvascular disease, diabetic retinopathy (DR) is also a retinal neurodegenerative process
A mean placebo-adjusted reduction of HbA1c up to 1.2% with the highest dose was also observed [28]
S L-serinamide (L-serine with the carboxylic acid group replaced with a carboxamide)
In comparison to GLP-1 WT, GLP-1 QMP and GLP-1 QMP/LX showed about 2-fold higher plasma concentrations, with about 48% and 42% of the administered doses detected in the blood after the distribution phase, respectively (Fig